Overview
No overview information available.
Background
No background information available.
Indication
用于胃食管反流病（GERD）的治疗。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/05/31 | Phase 1 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | ||
2023/07/14 | Phase 4 | Not yet recruiting | |||
2023/06/02 | N/A | Completed | Daewoong Pharmaceutical Co. LTD. | ||
2023/04/14 | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | ||
2023/04/13 | Phase 1 | Active, not recruiting | Daewoong Pharmaceutical Co. LTD. | ||
2022/12/21 | N/A | Active, not recruiting | Daewoong Pharmaceutical Co. LTD. | ||
2022/11/14 | N/A | Completed | Daewoong Pharmaceutical Co. LTD. | ||
2022/10/10 | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | ||
2022/03/31 | Phase 1 | Completed | Daewoong Pharmaceutical Co. LTD. | ||
2021/05/17 | Not Applicable | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||